<?xml version='1.0' encoding='utf-8'?>
<document id="23680637"><sentence text="Organic cation transporter 1 (OCT1/mOct1) is localized in the apical membrane of Caco-2 cell monolayers and enterocytes." /><sentence text="Organic cation transporters (OCTs) are members of the solute carrier 22 family of transporter proteins that are involved in absorption, distribution, and excretion of organic cations" /><sentence text=" OCT3 is localized in the apical (AP) membrane of enterocytes, but the literature is ambiguous about OCT1 (mOct1) localization, with some evidence suggesting a basolateral (BL) localization in human and mouse enterocytes" /><sentence text=" This is contrary to our preliminary findings showing AP localization of OCT1 in Caco-2 cell monolayers, an established model of human intestinal epithelium" /><sentence text=" Therefore, this study aims at determining the localization of OCT1 (mOct1) in Caco-2 cells, and human and mouse enterocytes" /><sentence text=" Functional studies using OCT1-specific substrate pentamidine showed transporter-mediated AP but not BL uptake in Caco-2 cells and human and mouse intestinal tissues"><entity charOffset="50-61" id="DDI-PubMed.23680637.s6.e0" text="pentamidine" /></sentence><sentence text=" OCT1 inhibition decreased AP uptake of pentamidine by ∼50% in all three systems with no effect on BL uptake"><entity charOffset="40-51" id="DDI-PubMed.23680637.s7.e0" text="pentamidine" /></sentence><sentence text=" A short hairpin RNA-mediated OCT1 knockdown in Caco-2 cells decreased AP uptake of pentamidine by ∼50% but did not alter BL uptake"><entity charOffset="84-95" id="DDI-PubMed.23680637.s8.e0" text="pentamidine" /></sentence><sentence text=" Immunostaining and confocal microscopy in all three systems confirmed AP localization of OCT1 (mOct1)" /><sentence text=" Our studies unequivocally show AP membrane localization of OCT1 (mOct1) in Caco-2 cells and human and mouse intestine" /><sentence text=" These results are highly significant as they will require reinterpretation of previous drug disposition and drug-drug interaction studies where conclusions were drawn assuming BL localization of OCT1 in enterocytes" /><sentence text=" Most importantly, these results will require revision of the regulatory guidance for industry in the United States and elsewhere because it has stated that OCT1 is basolaterally localized in enterocytes" /><sentence text=" " /></document>